Clinical trials
Acute Ischemic Stroke Patients clinical trials
Below are recruiting acute ischemic stroke patients clinical trials, each written for real people, not researchers. We’re tracking 420 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06696703Recruiting
Human urinary kallidinogenase for acute ischemic stroke
This trial tests whether a medicine called human urinary kallidinogenase can reduce inflammation after a stroke. It may help people who have had a first or recent stroke and have certain levels of disability.
Harbin, HeilongjiangAges 18 years+ - NCT06995625RecruitingPhase 1
Stem cell particles for recent stroke recovery
This trial tests whether stem cell-derived extracellular vesicles can help people recover after a moderate to severe stroke. You may join if you had a stroke in the last 5 days and still have arm or leg weakness, even after standard treatments like clot-busting drugs or clot removal.
Suwon, Gyeonggi-doAges 19 years+ - NCT06710028Recruiting
Using AI to improve stroke recovery
This trial tests if an artificial intelligence system can help improve outcomes for people who have had a stroke. If you have had an acute ischemic stroke, you may be able to join and help doctors learn if AI can guide better care.
LeuvenAges 18 years+ - NCT06712004RecruitingPhase 2
Testing a new stroke drug: different doses for people who cannot get standard care
This trial tests a new medication (bevifibatide) to see which dose works best for people having an ischemic stroke who cannot get standard treatments like clot-busting drugs or a procedure to remove the clot. It aims to improve recovery by stopping clots from getting worse.
Guangzhou, GuangdongAges 18–80 - NCT06726941Recruiting
Exercise and gene changes in stroke recovery
This study looks at how exercise affects certain genes and chemical changes in the body for people who have had a stroke. It may help find new ways to improve recovery after a stroke.
AfyonkarahisarAges 25–70 - NCT06727006Recruiting
Rescue stenting and clot-dissolving medicine for severe stroke
This trial tests whether using a stent plus a clot-dissolving drug can improve outcomes for people with a large-vessel stroke who are having a procedure to remove the clot. It is designed for patients who can receive treatment within 24 hours of their first symptoms.
Bergamo, ItalyAges 18 years+ - NCT06728592Recruiting
Emergency stroke unit for ischemic stroke within 6 hours
This trial tests a dedicated emergency stroke unit for people with ischemic stroke who can get treatment within 6 hours of symptoms starting. It aims to see if this special care area improves outcomes.
Hong KongAges 18–100 - NCT06733246Recruiting
Ceretrieve Device for acute ischemic stroke treatment
This study tests a new device called Ceretrieve that is designed to remove blood clots from large arteries in the brain for people having a severe ischemic stroke. If you are eligible, you will receive the device treatment (a mechanical thrombectomy) within 24 hours of your first symptoms.
HeidelbergAges 18 years+ - NCT06740942Recruiting
Studying nerve system changes after stroke with MRI and blood tests
This study looks at how the nervous system's automatic functions (like heart rate and blood pressure) change after a stroke. It uses MRI scans and blood tests to find patterns that might help doctors better understand and treat these changes.
Hamburg, Free and Hanseatic City of HamburgAges 18 years+ - NCT06741332Recruiting
AI software to speed up stroke clot removal referrals
This trial tests whether a special AI software can help doctors speed up the process of referring patients with acute stroke for a procedure that removes a blood clot (thrombectomy). If you have stroke symptoms and a recent CT scan, the AI may help identify if you could benefit from this treatment.
Granollers, BarcelonaAges 18 years+ - NCT06753006Recruiting
Research on stroke rehabilitation for arm weakness
This study tests a new rehabilitation program for people who have had a stroke within the last 6 months. It focuses on improving arm weakness using special therapy techniques.
Samara, Samara OblastAges 18–80 - NCT06758609Recruiting
Brain cooling plus clot removal for large artery stroke
This trial tests a new treatment that combines cooling the brain with a catheter and removing the clot to restore blood flow — for people who have had a major stroke in the front part of the brain within the last 24 hours.
Guangzhou, GuangdongAges 18–85 - NCT06759753RecruitingPhase 2
Aleeto for acute ischemic stroke: a randomized trial
This trial tests a drug called Aleeto in people who have had an acute ischemic stroke (a stroke caused by a blocked blood vessel) within the last 72 hours. It aims to see if Aleeto can improve recovery and reduce disability.
BeijingAges 30–80 - NCT06768138RecruitingPhase 3
Giving clot-busting medicine directly into the brain after successful blood flow restoration
This trial tests whether a clot-busting drug given directly into the brain artery can improve recovery after a major stroke caused by a blockage in the front part of the brain. The study is for people whose blood flow has already been successfully restored with standard treatments.
NancyAges 18 years+ - NCT06775782Recruiting
Remote conditioning for moderate stroke from large artery blockage
This trial tests whether a non-invasive arm cuff treatment (remote ischemic conditioning) can help people recover from a moderate stroke caused by a blockage in a major artery. You must start the treatment within 48 hours of your first symptoms.
Xi'an, ShaanxiAges 18–85 - NCT06783049Recruiting
Smartphone help to prevent another stroke after recent stroke or TIA
This trial tests a smartphone-based system that helps people who recently had a stroke or TIA manage their risk factors like high blood pressure or diabetes after leaving the hospital. It's designed to see if this tool can prevent another stroke.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06806397Recruiting
Brain imaging study of arm weakness after stroke
This study uses a light-based brain scanner (fNIRS) to understand how stroke affects arm movement. It may help find new ways to improve rehab.
MoscowAges 35–70 - NCT06817642Recruiting
Language recovery in stroke patients in intensive care
This study tests a new language assessment tool to predict how well stroke patients may recover their ability to speak and understand language. It may help identify who could benefit from early speech therapy.
CréteilAges 18–85 - NCT06823466Recruiting
Stroke study for patients on blood thinners
This study looks at people who had a stroke while taking blood thinners (anticoagulants) for an irregular heartbeat. It aims to learn more about these strokes and how to better prevent them in the future.
ZagrebAges 18 years+ - NCT06828679Recruiting
AI system to improve arm recovery after stroke
This trial tests whether an AI-powered system can help improve arm movement in people who had a stroke 1 to 6 months ago. It uses electrical stimulation to activate muscles and may lead to better recovery.
Hong Kong, Sha TinAges 65–80 - NCT06848894Recruiting
Study of a drug for stroke patients after blood clot treatment
This trial tests if adding a drug called human urinary kallidinogenase (HUK) can improve recovery for people who have had a stroke and already received clot-busting medicine or a procedure to remove the clot. The goal is to see if it helps reduce disability after a stroke.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06853535RecruitingPhase 3
Personalized antiplatelet therapy after stroke or TIA
This study tests whether guiding antiplatelet medication with a blood test can help prevent another stroke or TIA. It looks at people who have had a mild stroke or high-risk TIA within the last 48 hours.
Chengdu, SichuanAges 18 years+ - NCT06857487RecruitingPhase 1/Phase 2
Testing an herb formula to prevent early stroke worsening
This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.
Beijing, Beijing MunicipalityAges 18–80 - NCT06863571RecruitingPhase 3
Early medication combo to reduce swelling after stroke
This trial tests a combination of medicines given early after a large ischemic stroke to reduce brain swelling. It may help people who have had a stroke in the middle cerebral artery within the last 3 days and have a large area of brain damage.
Hangzhou, ZhejiangAges 18 years+
Hear when a new Acute Ischemic Stroke Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for acute ischemic stroke patients?
- Yes. Clin2 currently lists 420 recruiting acute ischemic stroke patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a acute ischemic stroke patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a acute ischemic stroke patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.